Sign in Subscribe
Chairpersons

Vaxart Chairman Michael J. Finney to Retire from Board of Directors

Strategic Insights

— 1 min read

Michael J. Finney, Ph.D., the Chairman of Vaxart, has announced his retirement from the Company's Board of Directors and Science and Technology Committee after a distinguished tenure of service. Finney's retirement will be effective September 30, 2025. In his statement, Finney expressed his pride in the Company's accomplishments and confidence in the team's ability to continue advancing the oral pill vaccine platform. Steven Lo, Chief Executive Officer, thanked Finney for his leadership, wisdom, and dedication, wishing him all the best.

Key Takeaways:

  • Michael J. Finney, Ph.D., Vaxart Chairman, has announced his retirement from the Board of Directors and Science and Technology Committee effective September 30, 2025.
  • Finney's retirement comes after a distinguished tenure of service, during which he has been a part of the Company's growth and mission.
  • The Board of Directors will meet this month to discuss leadership, composition, and governance issues, taking into account stockholder feedback to continue advancing the Company's scientific progress.
  • Vaxart is developing a range of oral recombinant vaccines based on its proprietary delivery platform, with programs including pill vaccines against coronavirus, norovirus, and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV).
  • The Company has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.

Statistics:

  • Effective date of Michael J. Finney's retirement: September 30, 2025.
  • Number of years of Finney's tenure on the Board of Directors and Science and Technology Committee: Not specified.
  • Number of vaccine programs under development by Vaxart: 4.
  • Number of patent applications filed by Vaxart: 14 (domestic and international).

Sources:

  • GlobeNewswire, "Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors and Science and Technology Committee" (September 2, 2025)
  • Vaxart, Inc., "About Vaxart" (no date)
  • Vaxart, Inc., "Note Regarding Forward-Looking Statements" (no date)

Read more